NSIS-B:CPH
Novozymes A/S
DKK 460.20
arrow_downward
-0.35%(-1.60) 1D
Oct 20, 10:23:31 AM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK 462.40
High
DKK 464.00
Low
DKK 459.50
Mkt. cap
188.58B
Avg. vol.
605.45K
Volume
25.45K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKK 462.40
High
DKK 464.00
Low
DKK 459.50
Mkt. cap
188.58B
Avg. vol.
605.45K
Volume
25.45K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
FXLeaders
·
23 minutes ago
Dow Futures Gain Short-Term Momentum Clashes With US Treasury Yields
FXStreet
·
1 hour ago
S&P 500: Tech rebound offsets broader weakness – Deutsche Bank
The Motley Fool
·
29 minutes ago
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Yahoo Finance
·
1 hour ago
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S